More articles from Drug Discovery and Translational Medicine

You have access
Intranasal Administration as a Route for Drug Delivery to the Brain: Evidence for a Unique Pathway for Albumin
Joseph A. Falcone, Therese S. Salameh, Xiang Yi, Benjamin J. Cordy, William G. Mortell, Alexander V. Kabanov and William A. Banks

Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 54-60; DOI: https://doi.org/10.1124/jpet.114.216705
You have access
Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen
George Mattheolabakis, Chi C. Wong, Yu Sun, Carol A. Amella, Robert Richards, Panayiotis P. Constantinides and Basil Rigas

Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 61-66; DOI: https://doi.org/10.1124/jpet.114.217208
You have access
Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Anaplastic Lymphoma Kinase and c-Ros Oncogene 1
Shinji Yamazaki, Justine L. Lam, Helen Y. Zou, Hui Wang, Tod Smeal and Paolo Vicini

Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 67-76; DOI: https://doi.org/10.1124/jpet.114.217141
You have access
Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
Ahmed Alhusban, Ahmad Al-Azayzih, Anna Goc, Fei Gao, Susan C. Fagan and Payaningal R. Somanath

Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 635-645; DOI: https://doi.org/10.1124/jpet.114.216382
You have access
DOT1L Inhibitor EPZ-5676 Displays Synergistic Antiproliferative Activity in Combination with Standard of Care Drugs and Hypomethylating Agents in MLL-Rearranged Leukemia Cells
Christine R. Klaus, Dorothy Iwanowicz, Danielle Johnston, Carly A. Campbell, Jesse J. Smith, Mikel P. Moyer, Robert A. Copeland, Edward J. Olhava, Margaret Porter Scott, Roy M. Pollock, Scott R. Daigle and Alejandra Raimondi

Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 646-656; DOI: https://doi.org/10.1124/jpet.114.214577
You have access
Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders
Mikhail Kalinichev, Emmanuel Le Poul, Christelle Boléa, Françoise Girard, Brice Campo, Massimiliano Fonsi, Isabelle Royer-Urios, Susan E. Browne, Jason M. Uslaner, Matthew J. Davis, Jacob Raber, Robert Duvoisin, Simon T. Bate, Ian J. Reynolds, Sonia Poli and Sylvain Celanire

Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 495-505; DOI: https://doi.org/10.1124/jpet.114.214437
You have access
NS19504: A Novel BK Channel Activator with Relaxing Effect on Bladder Smooth Muscle Spontaneous Phasic Contractions
Bernhard Nausch, Frederik Rode, Susanne Jørgensen, Antonio Nardi, Mads P. G. Korsgaard, Charlotte Hougaard, Adrian D. Bonev, William D. Brown, Tino Dyhring, Dorte Strøbæk, Søren-Peter Olesen, Palle Christophersen, Morten Grunnet, Mark T. Nelson and Lars C. B. Rønn

Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 520-530; DOI: https://doi.org/10.1124/jpet.113.212662
You have access
Vimocin and Vidapin, Cyclic KTS Peptides, Are Dual Antagonists of α₁β₁/α₂β₁ Integrins with Antiangiogenic Activity
Tatjana Momic, Jehoshua Katzehendler, Ofra Benny, Adi Lahiani, Gadi Cohen, Efrat Noy, Hanoch Senderowitz, Johannes A. Eble, Cezary Marcinkiewicz and Philip Lazarovici

Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 506-519; DOI: https://doi.org/10.1124/jpet.114.214643
You have access
Tanshinone II A Sulfonate, but Not Tanshinone II A, Acts as Potent Negative Allosteric Modulator of the Human Purinergic Receptor P2X7
M. Kaiser, H. Sobottka, W. Fischer, M. Schaefer and W. Nörenberg

Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 531-542; DOI: https://doi.org/10.1124/jpet.114.214569
You have access
Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering
Tracy Mitchell, Ginger Chao, Doree Sitkoff, Fred Lo, Hossain Monshizadegan, Daniel Meyers, Simon Low, Katie Russo, Rose DiBella, Fabienne Denhez, Mian Gao, Joseph Myers, Gerald Duke, Mark Witmer, Bowman Miao, Siew P. Ho, Javed Khan and Rex A. Parker

Journal of Pharmacology and Experimental Therapeutics August 2014, 350 (2) 412-424; DOI: https://doi.org/10.1124/jpet.114.214221

Main menu

User menu

Search

More articles from Drug Discovery and Translational Medicine

Pages

Navigate

More Information

ASPET's Other Journals